COMPANIES EYE COMMERCIAL OPPORTUNITIES
Indian startups are also looking to tap opportunities in the space-based research sector.
Chennai-based Inbound Aerospace is working to enable microgravity research in low-Earth orbit by transporting scientific experiments into space and returning them to Earth.
Inbound Aerospace’s co-founder Abhijit Bhutey said the company has partnerships with Australian and Japanese firms specialising in such payload development.
“Our job is, when the payload is ready, we carry it for them, put it in orbit for up to two months as per the requirement, and then we bring it back safely,” he said.
India’s expertise in biomanufacturing is also attracting interest from overseas space infrastructure developers.
Among them is United States-based HabSpace, which is developing plans for commercial space station infrastructure.
“Markets like India that have already established scale in biomanufacturing have a lot to teach us about what it takes and what is needed … to make sure that we are building the right infrastructure,” said HabSpace’s founder and CEO George Weinmann.
Despite the growing interest, commercial pharmaceutical manufacturing in space remains in its infancy.
The high costs of transporting research payloads to and from orbit, regulatory requirements and the long timelines needed to develop orbital infrastructure remain major challenges.
While the commercialisation of medicines manufactured in orbit may still be years away, India is positioning itself to tap into an emerging industry that looks set to transform the future of drug development.

